Genetic Predictors of Cardiovascular Mortality During Intensive Glycemic Control in Type 2 Diabetes: Findings From the ACCORD Clinical Trial

OBJECTIVE: To identify genetic determinants of increased cardiovascular mortality among subjects with type 2 diabetes who underwent intensive glycemic therapy in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. RESEARCH DESIGN AND METHODS: A total of 6.8 million common variants...

Descripción completa

Detalles Bibliográficos
Autores principales: Shah, Hetal S., Gao, He, Morieri, Mario Luca, Skupien, Jan, Marvel, Skylar, Paré, Guillaume, Mannino, Gaia C., Buranasupkajorn, Patinut, Mendonca, Christine, Hastings, Timothy, Marcovina, Santica M., Sigal, Ronald J., Gerstein, Hertzel C., Wagner, Michael J., Motsinger-Reif, Alison A., Buse, John B., Kraft, Peter, Mychaleckyj, Josyf C., Doria, Alessandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2016
Materias:
Emerging Science, Concepts, and Approach to Precision Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5079609/
https://www.ncbi.nlm.nih.gov/pubmed/27527847
http://dx.doi.org/10.2337/dc16-0285

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5079609/
https://www.ncbi.nlm.nih.gov/pubmed/27527847
http://dx.doi.org/10.2337/dc16-0285

Ejemplares similares